| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Achieved LDL cholesterol levels in patients with heterozygous familial hypercholesterolemia: A model that explores the efficacy of conventional and novel lipid-lowering therapy
|
Hartgers, Merel L.
|
|
2018
|
12 |
4 |
p. 972-980.e1
|
artikel
|
| 2 |
A novel homozygous ABCA1 variant in an asymptomatic man with profound hypoalphalipoproteinemia
|
Carcora, Yaser
|
|
2018
|
12 |
4 |
p. 878-882
|
artikel
|
| 3 |
Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia: Results from the SPIRE randomized trials of bococizumab
|
Ridker, Paul M
|
|
2018
|
12 |
4 |
p. 958-965
|
artikel
|
| 4 |
Case report—Rapid regression of xanthomas under lipoprotein apheresis in a boy with homozygous familial hypercholesterolemia
|
Katzmann, Julius
|
|
2018
|
12 |
4 |
p. 868-871
|
artikel
|
| 5 |
Clinical and biochemical features of different molecular etiologies of familial chylomicronemia
|
Hegele, Robert A.
|
|
2018
|
12 |
4 |
p. 920-927.e4
|
artikel
|
| 6 |
Clinical features and outcomes of severe, very severe, and extreme hypertriglyceridemia in a regional health service
|
Zafrir, Barak
|
|
2018
|
12 |
4 |
p. 928-936
|
artikel
|
| 7 |
Coronary computed tomographic angiography findings and their therapeutic implications in asymptomatic patients with familial hypercholesterolemia. Lessons from the SAFEHEART study
|
Pérez de Isla, Leopoldo
|
|
2018
|
12 |
4 |
p. 948-957
|
artikel
|
| 8 |
Dyslipidemia is associated with pediatric nonalcoholic fatty liver disease
|
Dowla, Shima
|
|
2018
|
12 |
4 |
p. 981-987
|
artikel
|
| 9 |
Editorial Board
|
|
|
2018
|
12 |
4 |
p. A1-A4
|
artikel
|
| 10 |
Elevated lipoprotein(a) and low-density lipoprotein cholesterol as predictors of the severity and complexity of angiographic lesions in patients with premature coronary artery disease
|
Chieng, David
|
|
2018
|
12 |
4 |
p. 1019-1026
|
artikel
|
| 11 |
Familial chylomicronemia syndrome: Bringing to life dietary recommendations throughout the life span
|
Williams, Lauren
|
|
2018
|
12 |
4 |
p. 908-919
|
artikel
|
| 12 |
Familial hypercholesterolemia with extensive coronary artery disease and tuberous and tendinous xanthomas: A case report and mutation analysis
|
Agirbasli, Deniz
|
|
2018
|
12 |
4 |
p. 863-867
|
artikel
|
| 13 |
From the editor: O Canada! A tariff-free zone for scientific exchange
|
Guyton, John R.
|
|
2018
|
12 |
4 |
p. 831-832
|
artikel
|
| 14 |
High-density lipoprotein cholesterol and causes of death in chronic kidney disease
|
Navaneethan, Sankar D.
|
|
2018
|
12 |
4 |
p. 1061-1071.e7
|
artikel
|
| 15 |
Highly efficacious, long-term, triglyceride lowering with rituximab therapy in a patient with autoimmune hypertriglyceridemia
|
Béliard, Sophie
|
|
2018
|
12 |
4 |
p. 883-887
|
artikel
|
| 16 |
Identification of proresolving and inflammatory lipid mediators in human psoriasis
|
Sorokin, Alexander V.
|
|
2018
|
12 |
4 |
p. 1047-1060
|
artikel
|
| 17 |
Immune-mediated acquired lecithin-cholesterol acyltransferase deficiency: A case report and literature review
|
Ishibashi, Ryoichi
|
|
2018
|
12 |
4 |
p. 888-897.e2
|
artikel
|
| 18 |
Low-density lipoprotein cholesterol response after statin initiation among persons living with human immunodeficiency virus
|
Burkholder, Greer A.
|
|
2018
|
12 |
4 |
p. 988-998.e5
|
artikel
|
| 19 |
News from the National Lipid Association
|
|
|
2018
|
12 |
4 |
p. 833-834
|
artikel
|
| 20 |
PCSK9 inhibitors for prevention of atherosclerotic cardiovascular disease
|
Bittner, Vera A.
|
|
2018
|
12 |
4 |
p. 835-843
|
artikel
|
| 21 |
PCSK9 monoclonal antibody on a knife-edge: An article of faith in FH?
|
Ward, Natalie C.
|
|
2018
|
12 |
4 |
p. 844-848
|
artikel
|
| 22 |
PHACTR1 genotype predicts coronary artery disease in patients with familial hypercholesterolemia
|
Paquette, Martine
|
|
2018
|
12 |
4 |
p. 966-971
|
artikel
|
| 23 |
Posttranslational modification of proprotein convertase subtilisin/kexin type 9 is differentially regulated in response to distinct cardiometabolic treatments as revealed by targeted proteomics
|
Gauthier, Marie-Soleil
|
|
2018
|
12 |
4 |
p. 1027-1038
|
artikel
|
| 24 |
Rethinking reverse cholesterol transport and dysfunctional high-density lipoproteins
|
Gillard, Baiba K.
|
|
2018
|
12 |
4 |
p. 849-856
|
artikel
|
| 25 |
R46L polymorphism in the PCSK9 gene: Relationship to lipid levels, subclinical vascular disease, and erectile dysfunction
|
Mostaza, Jose M.
|
|
2018
|
12 |
4 |
p. 1039-1046.e3
|
artikel
|
| 26 |
Severe xanthomatosis in heterozygous familial hypercholesterolemia
|
Aljenedil, Sumayah
|
|
2018
|
12 |
4 |
p. 872-877
|
artikel
|
| 27 |
Sex steroids mediate discrete effects on HDL cholesterol efflux capacity and particle concentration in healthy men
|
Rubinow, Katya B.
|
|
2018
|
12 |
4 |
p. 1072-1082
|
artikel
|
| 28 |
Table of Contents
|
|
|
2018
|
12 |
4 |
p. A5-A8
|
artikel
|
| 29 |
Temporal changes in statin prescription and intensity at discharge and impact on outcomes in patients with newly diagnosed atherosclerotic cardiovascular disease—Real-world experience within a large integrated health care system: The IMPRES study
|
Anderson, Jeffrey L.
|
|
2018
|
12 |
4 |
p. 1008-1018.e1
|
artikel
|
| 30 |
The burden of familial chylomicronemia syndrome: Results from the global IN-FOCUS study
|
Davidson, Michael
|
|
2018
|
12 |
4 |
p. 898-907.e2
|
artikel
|
| 31 |
The effect of eicosapentaenoic and docosahexaenoic acids on physical function, exercise, and joint replacement in patients with coronary artery disease: A secondary analysis of a randomized clinical trial
|
Alfaddagh, Abdulhamied
|
|
2018
|
12 |
4 |
p. 937-947.e2
|
artikel
|
| 32 |
Trends in high-intensity statin use and low-density lipoprotein cholesterol control among patients enrolled in a clinical pharmacy cardiac risk service
|
Lamprecht Jr., Donald G.
|
|
2018
|
12 |
4 |
p. 999-1007
|
artikel
|
| 33 |
Variations in time to benefit among clinical trials of cholesterol-lowering drugs
|
Barter, Philip J.
|
|
2018
|
12 |
4 |
p. 857-862
|
artikel
|
Tijdschrift beschrijving